Department of Radiation Oncology; School of Medicine, University of Virginia, Charlottesville, VA, USA.
Cell Cycle. 2013 Jul 15;12(14):2175-82. doi: 10.4161/cc.25314.
Deregulation of the cell cycle and genome instability are common features of cancer cells and various mechanisms exist to preserve the integrity of the genome and guard against cancer. The cullin 4-RING ubiquitin ligase (CRL4) with the substrate receptor Cdt2 (CRL4 (Cdt2)) promotes cell cycle progression and prevents genome instability through ubiquitylation and degradation of Cdt1, p21, and Set8 during S phase of the cell cycle and following DNA damage. Two recently published studies report the ubiquitin-dependent degradation of Cdt2 via the cullin 1-RING ubiquitin ligase (CRL1) in association with the substrate specificity factor and tumor suppressor FBXO11 (CRL1 (FBXO11)). The newly identified pathway restrains the activity of CRL4 (Cdt2) on p21 and Set8 and regulates cellular response to TGF-β, exit from the cell cycle and cellular migration. Here, we show that the CRL1 (FBXO11) also promotes the degradation of Cdt2 during an unperturbed cell cycle to promote efficient progression through S and G 2/M phases of the cell cycle. We discuss how this new method of regulating the abundance of Cdt2 participates in various cellular activities.
细胞周期失调和基因组不稳定性是癌细胞的常见特征,存在各种机制来保持基因组的完整性并预防癌症。细胞周期蛋白 4-RING 泛素连接酶(CRL4)与底物受体 Cdt2(CRL4(Cdt2))通过在细胞周期的 S 期以及 DNA 损伤后泛素化和降解 Cdt1、p21 和 Set8,促进细胞周期进程并防止基因组不稳定性。最近发表的两项研究报告了通过与底物特异性因子和肿瘤抑制因子 FBXO11(CRL1(FBXO11))相关的连接酶(CRL1)的泛素依赖性降解 Cdt2。新鉴定的途径限制了 CRL4(Cdt2)对 p21 和 Set8 的活性,并调节细胞对 TGF-β 的反应、退出细胞周期和细胞迁移。在这里,我们表明 CRL1(FBXO11)也在未受干扰的细胞周期中促进 Cdt2 的降解,以促进细胞周期的 S 和 G2/M 期的有效进展。我们讨论了这种调节 Cdt2 丰度的新方法如何参与各种细胞活动。